Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2455984

IR number 1793286
Words CYTEGRITY
Image
Image description
Status protected: Registered/protected
Priority date 20 Oct 2023 (Convention)
Classes 1, 5
Kind Word
Dates
Renewal due 13 Feb 2034
Registration advertised / published 24 Nov 2025
Entered on Register 24 Nov 2025
Acceptance advertised / published 17 Sep 2025
Acceptance 17 Sep 2025
IR notification 06 Jun 2024
Filing 13 Feb 2024
Registered from 13 Feb 2024

Owner Address for service
CSL Behring Gene Therapy, Inc.
Davies Collison Cave Pty Ltd

IR Contact

Scott D. Woldow Smith, Gambrell & Russell, LLP


Goods & Services
Class 1: Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines; cell lines for gene expression, and for synthesis of biological compounds; cells for gene expression and for synthesis of biological compounds; viral vectors.
Class 5: Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Biological preparations, namely, viral vectors and gene therapy vectors for therapeutic use and clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for treating a wide range of diseases, illnesses or conditions; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; viral vectors for gene therapy; gene therapy vectors.

Endorsements

Provisions of paragraph 44(3)(b) and/or Reg 4.15A(3)(b) applied.


Convention details
Date 20 Oct 2023
Number 98232757
Country UNITED STATES OF AMERICA

Indexing constituents
Word Image